Bath & Body Works, Inc. $BBWI Shares Bought by Blueshift Asset Management LLC

Blueshift Asset Management LLC lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 345.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 148,392 shares of the company’s stock after purchasing an additional 115,063 shares during the quarter. Bath & Body Works comprises about 1.4% of Blueshift Asset Management LLC’s investment portfolio, making the stock its 3rd largest position. Blueshift Asset Management LLC owned approximately 0.07% of Bath & Body Works worth $4,446,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Mutual of America Capital Management LLC increased its holdings in Bath & Body Works by 235.8% in the first quarter. Mutual of America Capital Management LLC now owns 111,471 shares of the company’s stock valued at $3,380,000 after buying an additional 78,280 shares in the last quarter. Cetera Investment Advisers grew its holdings in shares of Bath & Body Works by 8.9% in the 1st quarter. Cetera Investment Advisers now owns 27,091 shares of the company’s stock worth $821,000 after acquiring an additional 2,214 shares during the period. Federated Hermes Inc. purchased a new position in Bath & Body Works in the 1st quarter valued at approximately $754,000. Natixis Advisors LLC raised its holdings in Bath & Body Works by 0.7% during the first quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock worth $2,732,000 after purchasing an additional 629 shares during the last quarter. Finally, Chicago Partners Investment Group LLC purchased a new stake in Bath & Body Works during the first quarter worth $247,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insiders Place Their Bets

In related news, Director Stephen D. Steinour bought 6,700 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $14.86 per share, with a total value of $99,562.00. Following the completion of the transaction, the director owned 48,175 shares of the company’s stock, valued at approximately $715,880.50. The trade was a 16.15% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Francis Hondal bought 3,343 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average price of $14.99 per share, with a total value of $50,111.57. Following the completion of the acquisition, the director owned 21,554 shares of the company’s stock, valued at $323,094.46. This trade represents a 18.36% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 33,513 shares of company stock worth $500,442 over the last 90 days. Corporate insiders own 0.26% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on BBWI. Robert W. Baird restated a “neutral” rating and issued a $19.00 price target (down previously from $33.00) on shares of Bath & Body Works in a research report on Thursday, November 20th. Bank of America cut their target price on shares of Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Thursday, November 20th. Wells Fargo & Company reduced their price target on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, November 21st. Telsey Advisory Group lowered shares of Bath & Body Works from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $38.00 to $17.00 in a research report on Friday, November 21st. Finally, JPMorgan Chase & Co. cut their price objective on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, November 20th. Six equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $25.17.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $18.99 on Tuesday. The firm has a market cap of $3.89 billion, a P/E ratio of 5.64, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $41.87. The firm’s 50 day moving average price is $23.55 and its 200 day moving average price is $27.45.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.49 earnings per share. The company’s revenue was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, equities analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.